Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;129(2):291-299.
doi: 10.1111/1471-0528.16992. Epub 2021 Nov 23.

Universal newborn screening for congenital cytomegalovirus infection: feasibility and relevance in a French type-III maternity cohort

E Letamendia-Richard  1 , C Périllaud-Dubois  2   3 , L de La Guillonnière  1 , I Thouard  4 , A-G Cordier  5   6 , A-M Roque-Afonso  4   7 , D de Luca  1   8 , A Benachi  5 , C Vauloup-Fellous  4   7
Affiliations

Universal newborn screening for congenital cytomegalovirus infection: feasibility and relevance in a French type-III maternity cohort

E Letamendia-Richard et al. BJOG. 2022 Jan.

Abstract

Objective: Evaluation of relevance and feasibility of universal newborn congenital cytomegalovirus infection (cCMVI) screening in saliva.

Design: Retrospective, population-based cohort study.

Setting: Clamart, France, 2016-2020.

Population: All neonates born consecutively in our level III maternity unit.

Methods: CMV PCR in saliva for all neonates at birth, and, if positive, CMV PCR in urine to confirm or exclude cCMVI. Prospective and retrospective characterisation of maternal infections. ROC curve analysis to assess saliva PCR performances. Acceptability of screening among staff members evaluated by a survey.

Main outcome measures: Number of cCMVI neonates; number of expected and unexpected cCMVI.

Results: Among 15 341 tested neonates, 63 had cCMVI (birth prevalence of 0.4%, 95% CI 0.3-0.5). In 50% of cases, maternal infection was a non-primary infection (NPI) during pregnancy. cCMVI was expected or suspected (maternal primary infection [PI], antenatal or neonatal signs) in 24/63 neonates (38%), and unexpected in 39/63 neonates (62%). The best CMV saliva threshold to predict cCMVI was 356 (2.55 log) copies/ml [95% CI 2.52 log-3.18 log], with an area under the ROC curve of 0.97. Over 90% of the 72 surveyed staff members reported that the screening was easy and quick. No parent refused the screening.

Conclusions: Universal screening for cCMVI with CMV PCR on saliva samples is feasible and highly acceptable to parents and healthcare providers. Over half (62%) of the cases had no prenatal/neonatal signs of cCMVI or a maternal history of CMV infection during pregnancy and would probably not have been diagnosed without universal screening.

Tweetable abstract: In 62% of congenital cytomegalovirus infection cases, only universal neonatal screening in saliva can detect infection.

Keywords: Congenital cytomegalovirus; neonatal screening; non-primary infection; saliva.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253-76.
    1. Leruez-Ville M, Foulon I, Pass R, Ville Y. Cytomegalovirus infection during pregnancy: state of the science. Am J Obstet Gynecol 2020;223:330-49.
    1. Coll O, Benoist G, Ville Y, Weisman LE, Botet F, Anceschi MM, et al. Guidelines on CMV congenital infection. J Perinat Med 2009;37:433-45.
    1. Nagel A, Dimitrakopoulou E, Teig N, Kern P, Lücke T, Michna D, et al. Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assay. PLoS One 2020;15:e0227143.
    1. Kimberlin DW, Jester PM, Sánchez PJ, Ahmed A, Arav-Boger R, Michaels MG, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 2015;372:933-43.

Publication types